Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on holter and a left ventricular ejection fraction below 30%

Journal of the American College of Cardiology

Volumn 39, Issue 5, 2002, Pages 780-787

  Grimm, Wolfram ^a   Hoffmann, J urgen ^a   Müller, Hans Helge ^a   Maisch, Bernhard ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROPHYLAXIS; SUDDEN DEATH; SYMPTOMATOLOGY; SYNCOPE;

ADOLESCENT; ADULT; AGED; CARDIAC OUTPUT, LOW; CARDIOMYOPATHY, DILATED; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; STROKE VOLUME; SYNCOPE; TACHYCARDIA, VENTRICULAR; TIME FACTORS; VENTRICULAR FIBRILLATION;

EID: 0037028893     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01822-8     Document Type: Article

References (27)

1. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias
2. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmic devices: A report of ACC/AHA Task Force on Practice Guidelines
3. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia
4. Multicenter randomized trial comparing amiodarone to implantable defibrillator in patients with nonischemic cardiomyopathy and asymptomatic nonsustained ventricular tachycardia: AMIOVIRT trial
5. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia
6. Risk stratification for arrhythmic events in patients with nonischemic dilated cardiomyopathy and nonsustained ventricular tachycardia: Role of programmed ventricular stimulation and the signal-averaged electrocardiogram
7. Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator
8. Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator
9. Arrhythmia risk stratification in idiopathic dilated cardiomyopathy based on echocardiography, 12-lead electrocardiogram, signal-averaged electrocardiogram and 24-hour Holter electrocardiogram
10. Ventricular arrhythmias in dilated cardio-myopathy as an independent prognostic hallmark
11. Nonsustained ventricular tachycardia in severe heart failure - Independent marker of increased mortality due to sudden death
12. Implantable cardioverter defibrillator: Use in patients with no symptoms and at high risk
13. Defibrillators in nonischemic cardiomyopathy treatment evaluation
14. Clinical guideline. Diagnosing syncope. Part 2: Unexplained syncope
15. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography
16. Value of ventricular electrogram recordings in the diagnosis of arrhythmias precipitating electrical device shock therapy
17. ICD data storage: Value in arrhythmia management
18. Use of bipolar recordings from patch-patch and rate sensing leads to distinguish ventricular tachycardia from supraventricular rhythms in patients with implantable cardioverter defibrillators
19. Do patients with an implantable defibrillator live longer?
20. Potential benefit from implantable cardioverter-defibrillator therapy in patients with and without heart failure
21. Long-term follow-up of patients with nonischemic dilated cardiomyopathy and ventricular tachyarrhythmias treated by implantable cardioverter defibrillators
22. Shock occurrence and survival in 49 patients with idiopathic dilated cardiomyopathy and implantable cardioverter-defibrillator
23. Clusters of ventricular tachycardia signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators
24. Complications of third generation implantable cardioverter defibrillator therapy
25. Cardiomyopathy trial
26. New primary prevention trial of sudden cardiac death in patients with left ventricular dysfunction: SCD-HeFT and MADIT II
27. Prediction of major arrhythmic events and sudden cardiac death in dilated cardiomyopathy - The Marburg Cardiomyopathy study design and description of baseline characteristics